Company profile: BioChain
1.1 - Company Overview
Company description
- Provider of technology and products for the life science research community, including cfPure® cell-free DNA extraction kits to isolate cfDNA from plasma, serum, and urine for NGS and PCR; high-quality biospecimens; reagents; pre-packaged laboratory kits; and automated instruments to automate processes and enhance efficiency in sample preparation and analysis.
Products and services
- Biospecimens: Research-grade, high-quality biological samples used for research and diagnostic purposes within the life science research community
- Reagents: Analytical-grade chemical substances used in laboratory experiments to detect, measure, examine, or produce other substances for the life science research community
- CfPure® Cell-Free DNA Extraction Kit: Magnetic bead-based kit engineered to isolate circulating cell-free DNA from plasma, serum, and urine for Next-Generation Sequencing and PCR
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioChain
Mammoth Biosciences
HQ: United States
Website
- Description: Provider of CRISPR-based diagnostics, therapeutics, and protein discovery solutions. The DETECTR Platform delivers instrument-free nucleic acid detection for disease; therapeutics offer precision genome editing using novel CRISPR-Cas enzymes; and a proprietary platform discovers new CRISPR systems and Cas proteins for applications in research, agriculture, and biodefense.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mammoth Biosciences company profile →
oncgnostics
HQ: Germany
Website
- Description: Provider of proprietary epigenetic biomarker-based in vitro diagnostic (IVD) tests for cancer screening, therapeutic decisions, and follow-up care, including GynTect and ScreenYu Gyn for detecting methylated DNA regions in cervical cells (ScreenYu Gyn suited for automation and large-scale screening), and saliva-based head and neck tumor diagnostics using DNA methylation markers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full oncgnostics company profile →
Evonetix
HQ: United Kingdom
Website
- Description: Provider of a benchtop platform that synthesizes, assembles, and error-corrects gene-length DNA on a silicon chip with unprecedented accuracy and scale using thermal control of DNA synthesis. Offers chip technology to synthesize thousands of oligonucleotide sequences simultaneously, binary assembly, and thermal error removal for rapid, precise gene synthesis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evonetix company profile →
Day Zero Diagnostics
HQ: United States
Website
- Description: Provider of whole-genome sequencing–based tools and services for clinical pathogen detection, antimicrobial resistance profiling, and outbreak management, including Blood2Bac to enrich bacterial DNA directly from blood; Keynome ID for species identification; Keynome gAST for resistance profiling; MicrohmDB to support machine learning; and epiXact for pathogen relatedness insights for infection control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Day Zero Diagnostics company profile →
Microsynbiotix
HQ: Ireland
Website
- Description: Provider of technology to eliminate excessive antibiotic use in farmed fish by engineering microalgae, leveraging advances in algal genomics and molecular biology to express inexpensive therapeutic proteins and vaccines of economic value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microsynbiotix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioChain
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioChain
2.2 - Growth funds investing in similar companies to BioChain
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioChain
4.2 - Public trading comparable groups for BioChain
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →